全文获取类型
收费全文 | 59787篇 |
免费 | 5652篇 |
国内免费 | 4242篇 |
专业分类
耳鼻咽喉 | 614篇 |
儿科学 | 549篇 |
妇产科学 | 576篇 |
基础医学 | 6869篇 |
口腔科学 | 1201篇 |
临床医学 | 7835篇 |
内科学 | 8593篇 |
皮肤病学 | 675篇 |
神经病学 | 2632篇 |
特种医学 | 1923篇 |
外国民族医学 | 41篇 |
外科学 | 6024篇 |
综合类 | 10723篇 |
现状与发展 | 19篇 |
一般理论 | 14篇 |
预防医学 | 4558篇 |
眼科学 | 1677篇 |
药学 | 6390篇 |
66篇 | |
中国医学 | 3485篇 |
肿瘤学 | 5217篇 |
出版年
2024年 | 237篇 |
2023年 | 935篇 |
2022年 | 2361篇 |
2021年 | 3177篇 |
2020年 | 2353篇 |
2019年 | 1931篇 |
2018年 | 2075篇 |
2017年 | 1836篇 |
2016年 | 1697篇 |
2015年 | 2840篇 |
2014年 | 3406篇 |
2013年 | 2966篇 |
2012年 | 4284篇 |
2011年 | 4751篇 |
2010年 | 3292篇 |
2009年 | 2670篇 |
2008年 | 3184篇 |
2007年 | 3183篇 |
2006年 | 3168篇 |
2005年 | 3053篇 |
2004年 | 2253篇 |
2003年 | 2096篇 |
2002年 | 1709篇 |
2001年 | 1458篇 |
2000年 | 1347篇 |
1999年 | 1367篇 |
1998年 | 919篇 |
1997年 | 865篇 |
1996年 | 637篇 |
1995年 | 667篇 |
1994年 | 557篇 |
1993年 | 327篇 |
1992年 | 371篇 |
1991年 | 335篇 |
1990年 | 289篇 |
1989年 | 249篇 |
1988年 | 203篇 |
1987年 | 198篇 |
1986年 | 135篇 |
1985年 | 114篇 |
1984年 | 65篇 |
1983年 | 38篇 |
1982年 | 22篇 |
1981年 | 27篇 |
1980年 | 8篇 |
1979年 | 22篇 |
1977年 | 2篇 |
1976年 | 1篇 |
1971年 | 1篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
51.
氟哌啶醇季铵盐衍生物的合成及其对冠状动脉的作用 总被引:3,自引:1,他引:2
目的 :合成氟哌啶醇季铵盐衍生物并研究其对动物冠状动脉的作用。方法 :以氟哌啶醇为原料 ,将其与卤代烃在回流的情况下进行反应而得到其季铵盐衍生物。采用猪冠状动脉条生物测定法和Langendorff灌流法研究这些衍生物对冠状动脉的作用。结果 :合成了 7个新化合物 ( 1~ 7) ,其中化合物 7量效依赖地压低KCl所致的猪冠状动脉条收缩曲线 ,阻断较大剂量所致的冠状动脉条痉挛 ,并量效依赖地拮抗脑垂体后叶素所致的离体豚鼠心脏冠脉流量减少。结论 :化合物 7显示了良好的扩张冠状动脉的作用 ,值得进一步研究 相似文献
52.
老年脑梗死患者急性期血小板活化功能定量检测 总被引:11,自引:2,他引:9
目的 :探讨老年脑梗死患者外周血中血小板膜糖蛋白变化的临床意义。 方法 :应用流式细胞术检测了 6 8例急性期老年脑梗死患者外周血血小板活化分子标记物CD4 1、CD6 2p和CD6 3的含量水平 ,与 4 2例正常老年人对照 ;并对脑梗死组病灶大小、梗死部位、病情分级等与血小板活化分子表达的变化进行分析 ,应用统计学进行处理。 结果 :急性期脑梗死患者血小板粘附分子CD4 1、CD6 2 p和CD6 3的表达水平显著高于正常对照组 (P <0 .0 1) ,且与梗死灶大小及病情分级密切相关 ,与梗死部位无关。 结论 :老年脑梗死患者急性期外周血血小板活化功能明显增强 ,为早期应用抗血小板聚集药物的治疗提供了实验依据 相似文献
53.
比索洛尔改善充血性心衰心功能及心肌重塑的疗效观察 总被引:5,自引:1,他引:4
目的 观察比索洛尔 (bisoprolol)对充血性心衰心功能及心肌重塑的临床疗效 .方法 2 12例患者随机分为比索洛尔组和常规药物组 ,比索洛尔剂量起始量 0 .6 2 5 mg~1.2 5 0 mg,1次· d- 1 ,逐渐增加至最大剂量为 2 .5 mg~ 5 .0mg,1次· d- 1 .观察心功能、临床疗效、左室舒张末内径(L VEDD)、左室收缩末内径 (L VESD)、射血分数 (EF)、舒张早期 E峰流速 /舒张晚期 A峰流速 (VE/ VA) .结果 比索洛尔组与常规药物组比较 ,比索洛尔治疗 3m o后有效者(87.7% )高于常规药物组 (6 6 .0 % ) ,P <0 .0 5 ;冠心病(87.9% )和扩张型心肌病心衰 (91.9% )疗效明显好于常规药物组 (分别为 6 6 .7% ,6 7.4 % ) ;治疗 6 mo后重度心衰者疗效(90 .0 % )明显好于常规药物组 (6 5 .4 % ,P <0 .0 5 ) .治疗后比索洛尔组 L VESD[(44 .8± 3.9) m m vs(48.8± 4 .6 ) mm],EF[(40 .7± 7.5 ) % vs (35 .7± 5 .2 ) % ]优于常规药物组 (P<0 .0 1) ;L VEDD,VE/ VA也较治疗前有明显改善 .结论 比索洛尔改善充血性心力衰竭临床症状 ,促进心脏收缩、舒张功能恢复 ,部分逆转心肌重塑 . 相似文献
54.
目的:分析胸腰段脊柱前路手术入路并发症,以提高胸腰段脊柱前路手术的水平,方法:对近4年来我科53例胸腰段脊柱前路手术出现的5例并发症进行回顾性分析,探讨并发症发生的原因。结果;本组病例1例发生腹膜后乳糜液漏,1例切口疝,1例气胸,2例深静脉血栓栓塞,经过积极治疗,全部治愈。结论:胸腰段脊柱前路手术并发症的发生大多数和术者对该段解剖知识,手术操作,认识程度和经验有关,可以避免或及早发现。 相似文献
55.
善存片联合健脾理气中药预防肿瘤患者化疗所致口腔溃疡的临床观察 总被引:1,自引:0,他引:1
目的观察在全身化疗前应用善存片联合健脾理气中药对肿瘤患者口腔溃疡的预防作用。方法将66例肿瘤患者随机分配为治疗组和对照组,每组33例。在全身静脉化疗前3天开始,治疗组每天口服善存片1片及健脾理气中药1剂,对照组服用维生素B:治疗,两组服药化疗后10天为1个疗程。每周期化疗结束后统计口腔溃疡的发生率,共4周期。结果治疗组口腔溃疡的发生率显著降低(P〈0.01)。结论善存片联合健脾理气中药可有效预防及治疗肿瘤患者化疗所致的口腔溃疡。 相似文献
56.
Naiquan Zheng Rafael F Escamilla Glenn S Fleisig Kevin E Wilk James R Andrews 《中华骨科杂志》2002,29(1):697-700
结果 髌股关节的压力与应力随膝关节屈曲角度的增加而升高,随膝关节屈曲角度的减小而降低(图3~8).不同膝关节屈曲角度下弓步变化和跨步变化的髌股关节压力见表1. 相似文献
57.
保留肾单位手术治疗早期小肾癌21例临床分析 总被引:1,自引:0,他引:1
Yao-Jun Xiao Shao-Bin Zheng Wan-Long Tan Tong Chen Huan Qi Zhi-Qiang Shao Yao-Dong Jiang Peng Wu Hui-Jian Zhang 《第一军医大学学报》2005,25(3):357-359
OBJECTIVE: To evaluate the clinical effects of nephron-sparing surgery in patients with early-stage small renal cell carcinoma. METHODS: Nephron-sparing surgery was performed in 21 patients with renal cell carcinoma including 1 with solitary kidney, 3 with unilateral tumor and contralateral renal compromise, and 17 with unilateral tumor and normal contralateral kidney. The diameter of the tumors ranged from 1.5 to 6.0 cm, with a mean of 2.8 cm. The tumor diameter in 17 patients with normal contralateral kidney was less than 4 cm (mean 2.5 cm) and the average diameter in 4 patients with contralateral renal compromise was 4.2 cm. Sixteen cases were in stage T(1), 4 in stage T(2), and 1 in stage T(3). Of the 21 patients, 4 underwent tumor enucleation, 10 polar nephrectomy and 7 wedge resection. RESULTS: All patients were followed up for an average of 40.8 months (7 to 66 months). One patient suffered a right lung and mediastinum metastasis 3 years after the surgery later and 1 with chronic glomerulonephritis required dialysis 27 months after the operation. No surgical complication or local recurrence were found in other patients. CONCLUSION: As a safe and effective therapy for early-stage small renal cell carcinoma, nephron-sparing surgery can be considered as the gold-standard therapy for patients with lesions less than 4 cm in T(1) and T(2) stages of localized unilateral tumor with normal contralateral kidney. 相似文献
58.
Jing‐Ping Zhang Limin Zheng Jiang‐Hai Wang Karl‐Eric Magnusson Xin Liu 《Phytotherapy research : PTR》2009,23(6):844-850
Ganoderma sinensis has been used widely in Oriental countries for the prevention and treatment of various diseases including cancer. Previous studies have shown that the lipid extract from Ganoderma exhibits direct cytotoxicity against tumor cells. Here, it is reported that the lipid extract from germinating G. sinensis spores, at lower concentrations that have no direct tumoricidal activity, induce potent antitumor immune responses in human monocytes/macrophages. Upon stimulation with the lipid extract, monocytes/macrophages exhibited markedly increased production of proinflammatory cytokines and surface expression of costimulatory molecules. Conditioned medium from stimulated cells effectively suppressed the growth of tumor cells. Apparently, the lipid extract triggered macrophage activation via a mechanism different from that associated with LPS. Moreover, it was observed that the lipid extract could partially re‐establish the antitumor activity of the immunosuppressive tumor‐associated macrophages. These results indicated that in addition to its direct tumoricidal activity, the lipid extract from G. sinensis spores could exert antitumor activity by stimulating the activation of human monocytes/macrophages. Copyright © 2008 John Wiley & Sons, Ltd. 相似文献
59.
We analyzed the membrane potential of 161 respiratory neurons in the medulla of decerebrate rats which were paralyzed and ventilated. Three types of inspiratory (I) neurons were observed: those displaying progressive depolarization in inspiration (augmenting I neurons), those which gradually repolarized after maximal depolarization at the onset of inspiration (decrementing I neurons) and those exhibiting a plateau or bell-shaped membrane potential trajectory throughout inspiration (I-all neurons). Three types of expiratory (E) neurons were also encountered: those in which the membrane potential progressively depolarized (augmenting E neurons), those in which the membrane potential repolarized during the interval between phrenic bursts (decrementing E or post-I neurons) and those exhibiting a plateau or bell-shaped membrane potential trajectory throughout expiration (E-all neurons). Axonal projections of these medullary neurons were identified in the cranial nerves (n = 34), or in the spinal cord (n = 19) as revealed by antidromic stimulation and/or by reconstruction following horseradish peroxidase (HRP) labeling. The other 108 neurons were not antidromically activated (NAA) by the stimulations tested, or had their axons terminating inside the medulla as revealed by HRP labeling. All these respiratory neurons, except for 3 which were hypoglossal motoneurons, had their somata within the ventrolateral medulla, in the region of the nucleus ambiguus, homologous to the ventral respiratory group (VRG) of the cat. No dorsal respiratory group (DRG) was detected within the medulla of the rats. Due to this absence of a DRG, it is concluded that the neural organization of respiratory centers is quite different in cats and rats. 相似文献
60.
原位杂交法检测BP1基因在乳腺癌组织中表达 总被引:3,自引:0,他引:3
目的探讨BP1同源盒基因在乳腺癌中的表达及其与临床病理指标的关系。方法收集165例乳腺癌临床和病理资料,采用原位杂交法检测BP1的表达,同时用二步法进行ER、p53、PCNA、bcl2、cerbB2免疫组化染色。结果BP1基因表达率为67.88%,免疫组化:ER70.30%、p5349.09%、PCNA74.55%、bcl253.33%、cerbB275.52%。BP1与bcl2具有相关性(P<0.01),且均与ER相关(P<0.05),与p53呈负相关(P<0.05)。BP1与PCNA、cerbB2、患者年龄、组织学类型、淋巴结转移等无相关性。结论BP1可能通过某种非依赖p53基因调控机制,与bcl2、ER协同抑制肿瘤细胞的凋亡而参与乳腺癌的发生。 相似文献